vimarsana.com

Page 10 - புதுமையானது மருந்துகள் முயற்சி News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Plenaire vergadering Europees Parlement, Brussel

Europees Parlement (EP) Het Europees Parlement (EP) vertegenwoordigt ruim 450 miljoen Europeanen en bestaat momenteel uit 705 afgevaardigden (inclusief voorzitter). Nederland heeft 29 zetels in het Europees Parlement. Het Europees Parlement wordt geacht een stem te geven aan de volkeren van de 27 landen die aan de Unie deelnemen, en vooral te letten op het belang van de Unie in zijn geheel. De leden van het Europees Parlement worden om de vijf jaar rechtstreeks gekozen door de burgers van de Europese Unie. De volgende verkiezingen zijn in 2024. Het Parlement debatteert op basis van voorstellen van de Europese Commissie en kan daarbij wijzigingen voorstellen, waarna het Parlement samen met de Raad van de Europese Unie een beslissing over deze voorstellen neemt.

For Japan s Top CEOs, It s Change or Die | Institutional Investor

Sponsored Constant evolution in the face of challenges is what unites the top-scoring chief executives in Institutional Investor’s 2021 All-Japan Executive Team. Shigenobu Nagamori, chairman and chief executive of Nidec Corp., quotes Nietzsche: “The snake which cannot cast its skin has to die.” Nagamori is once again the top-scoring chief executive in the electronic components sector for his work at Nidec, the company he founded in a prefabricated hut along the Katsura River in Kyoto in 1973. For more than 10 years, he has been searching for a successor for his business. But few hopefuls can match his resolve: After his father passed away when he was a child, Nagamori’s mother, a farmer, told him that as long as he put in twice as much effort as others, he would succeed in his endeavors. 

The Blood-Clot Problem Is Multiplying

The Blood-Clot Problem Is Multiplying Roxanne Khamsi © Provided by The Atlantic DeAgostini / Getty / Katie Martin / The Atlantic For weeks, Americans looked on as other countries grappled with case reports of rare, sometimes fatal blood abnormalities among those who had received the AstraZeneca vaccine against COVID-19. That vaccine has not yet been authorized by the FDA, so restrictions on its use throughout Europe did not get that much attention in the United States. But Americans experienced a rude awakening this week when public-health officials called for a pause on the use of the Johnson & Johnson vaccine, after a few cases of the same, unusual blood-clotting syndrome turned up among the millions of people in the country who have received it.

Industry lobby to co-decide on nearly €10bn EU public money

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.